Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,432 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03068936 | IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma | unknown | Phase 3 | 716 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Mar 3, 2017 | clinicaltrials |
| NCT03015727 | Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma(IRCNPC) | unknown | Phase 3 | 440 | Zhejiang Cancer HospitalOTHER | 1 | Jan 10, 2017 |
| clinicaltrials |
| NCT00002727 | Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord | completed | Phase 3 | 250 | Radiation Therapy Oncology GroupNETWORK | 2 | Jan 4, 2017 | clinicaltrials |
| NCT03006588 | EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) Patients | unknown | Phase 2 / Phase 3 | 100 | Sun Yat-sen UniversityOTHER | 1 | Jan 2, 2017 | clinicaltrials |
| NCT00131638 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer | completed | Phase 3 | 241 | AmgenINDUSTRY | 0 | Dec 16, 2016 | clinicaltrials |
| NCT00002533 | Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer | completed | Phase 2 / Phase 3 | — | University of MiamiOTHER | 1 | Dec 15, 2016 | clinicaltrials |
| NCT01083550 | Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer | completed | Phase 2 / Phase 3 | 74 | University Health Network, TorontoOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT00412217 | A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer | terminated | Phase 3 | 94 | Hoffmann-La RocheINDUSTRY | 1 | Nov 25, 2016 | clinicaltrials |
| NCT00496652 | DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC | completed | Phase 3 | 619 | Danish Head and Neck Cancer GroupNETWORK | 1 | Nov 25, 2016 | clinicaltrials |
| NCT01507467 | IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck(IAEA-HypoX) | terminated | Phase 3 | 104 | Danish Head and Neck Cancer GroupNETWORK | 4 | Nov 25, 2016 | clinicaltrials |
| NCT01540136 | Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma | completed | Phase 3 | 402 | Sun Yat-sen UniversityOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02944708 | Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 384 | Shanghai Proton and Heavy Ion CenterOTHER | 3 | Oct 27, 2016 | clinicaltrials |
| NCT00101582 | Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer | completed | Phase 3 | 188 | Swedish Orphan BiovitrumINDUSTRY | 0 | Sep 27, 2016 | clinicaltrials |
| NCT02907710 | Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 300 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT00036881 | Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer | completed | Phase 3 | 173 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 14, 2016 | clinicaltrials |
| NCT00003610 | Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy | completed | Phase 3 | 18 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00041171 | Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT02048254 | Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer | unknown | Phase 3 | 90 | Peking UniversityOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT02786641 | Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 235 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT00174837 | TRACE: Tirapazamine-Radiation And Cisplatin Evaluation(TRACE) | completed | Phase 3 | 317 | SanofiINDUSTRY | 17 | May 26, 2016 | clinicaltrials |
| NCT00537199 | OraTest in Combination With Visual Examination and Visual Examination Alone | terminated | Phase 3 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT00795782 | Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma | completed | Phase 3 | 258 | Samsung Medical CenterOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT01212354 | Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT(Escalox) | unknown | Phase 3 | 270 | Technical University of MunichOTHER | 1 | Feb 9, 2016 | clinicaltrials |
| NCT01161498 | Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer | terminated | Phase 3 | 5 | BioVex LimitedINDUSTRY | 2 | Feb 8, 2016 | clinicaltrials |
| NCT00412776 | Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer | terminated | Phase 2 / Phase 3 | 165 | Sesen Bio, Inc.INDUSTRY | 18 | Dec 23, 2015 | clinicaltrials |
| NCT02303197 | Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis | completed | Phase 3 | 70 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02633176 | Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Dec 17, 2015 | clinicaltrials |
| NCT02621970 | Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma | unknown | Phase 3 | 534 | Sun Yat-sen UniversityOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT02610010 | Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma | unknown | Phase 3 | 462 | Sun Yat-sen UniversityOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00006994 | S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat | terminated | Phase 3 | 23 | SWOG Cancer Research NetworkNETWORK | 2 | Nov 18, 2015 | clinicaltrials |
| NCT00003139 | Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer | completed | Phase 3 | 249 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT02282839 | Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation | unknown | Phase 3 | 60 | Taichung Veterans General HospitalOTHER | 1 | Nov 4, 2015 | clinicaltrials |
| NCT01074021 | Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer | unknown | Phase 3 | 480 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Oct 30, 2015 | clinicaltrials |
| NCT02537925 | The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma | unknown | Phase 3 | 120 | Changjie HuangOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT02500940 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 54 | Taichung Veterans General HospitalOTHER | 1 | Jul 17, 2015 | clinicaltrials |
| NCT01012258 | Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects(CHANCE) | completed | Phase 3 | 70 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Jul 9, 2015 | clinicaltrials |
| NCT00147732 | Randomized Trial of ARCON in Larynx Cancer | completed | Phase 3 | 345 | Radboud University Medical CenterOTHER | 2 | May 7, 2015 | clinicaltrials |
| NCT00088907 | Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer | terminated | Phase 3 | 270 | National Cancer Institute (NCI)NIH | 1 | May 6, 2015 | clinicaltrials |
| NCT01228565 | Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®(GORTEC 2009-01) | completed | Phase 3 | 76 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01596933 | Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy(NUTRIOM) | completed | Phase 2 / Phase 3 | 91 | General Hospital GroeningeOTHER | 1 | Mar 10, 2015 | clinicaltrials |
| NCT00201396 | A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | completed | Phase 3 | 480 | National Health Research Institutes, TaiwanOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT00934739 | A Study of High-Risk Oral Cavity Cancer | terminated | Phase 2 / Phase 3 | 150 | National Health Research Institutes, TaiwanOTHER | 0 | Feb 25, 2015 | clinicaltrials |
| NCT01086826 | Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck(H&N07) | completed | Phase 3 | 320 | Associazione Volontari Pazienti OncologiciOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01915134 | Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 362 | Zhejiang Cancer HospitalOTHER | 1 | Jan 1, 2015 | clinicaltrials |
| NCT02301208 | Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma(NPC-RCT-WCRT) | unknown | Phase 3 | 120 | He XiaOTHER | 0 | Dec 8, 2014 | clinicaltrials |
| NCT00022373 | Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer | unknown | Phase 3 | — | National Cancer Institute (NCI)NIH | 1 | Oct 15, 2014 | clinicaltrials |
| NCT01039298 | Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL | unknown | Phase 3 | 200 | University of British ColumbiaOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT01177956 | A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck(CHANGE) | completed | Phase 3 | 73 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 2 | Sep 3, 2014 | clinicaltrials |
| NCT00911326 | Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma | terminated | Phase 3 | 101 | Navidea BiopharmaceuticalsINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | completed | Phase 3 | 442 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 17 | Jul 23, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Mar 3, 2017source: clinicaltrials